Helena Moza

Featured in: Favicon

academic.oup.com

Articles

Safety and Immunogenicity of Respiratory Syncytial Virus Prefusion F Protein Vaccine when Co-administered with Adjuvanted Seasonal Quadrivalent Influenza Vaccine in Older Adults: A Phase 3 Randomized Trial

Aug 5, 2024 | academic.oup.com | Tropical Diseases |CHU Nîmes |Natalini Martínez |Helena Moza

Respiratory syncytial virus (RSV) is a major cause of acute respiratory illness [1]. In addition to infants, people of advanced age and those with certain underlying medical conditions (eg, heart or lung disease and diabetes) are at increased risk for severe RSV disease [2–6].

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →